
Acambis's Universal Influenza Vaccine Enters Phase 1 Trial
Acambis plc (Cambridge, UK, www.acambis.com) has initiated a Phase 1 clinical trial of its universal influenza vaccine candidate, ACAM-FLU-A.
Acambis plc (Cambridge, UK,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.